Epidarex adds three to advisory board

Bethesda, Maryland and UK-based Epidarex Capital, an early-stage life science venture firm, has named Dr. William R Sellers, William Burns and Dr. Frank M Armstrong to its advisory board. Sellers is the former vice president and global head of oncology at the Novartis Institutes for BioMedical Research; Burns was the CEO of Roche Pharmaceuticals; and Armstrong has led development improvement programs at Merck Serono, Zeneca and Bayer.

North AmericaUSHuman ResourcesBriefs